Incorporating early cfEBV DNA clearance into clinical risk stratification to tailor induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma.
Saved in:
| Title: | Incorporating early cfEBV DNA clearance into clinical risk stratification to tailor induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma. |
|---|---|
| Authors: | Guo, Wan-Ping1 (AUTHOR), Yu, Xuan1 (AUTHOR), Lu, Zi-Jian2 (AUTHOR), Li, Yu-Chen1 (AUTHOR), Wu, Chun1 (AUTHOR), Gu, Li-Wen1 (AUTHOR), Cao, Jing-Na1 (AUTHOR), Luo, Dong-Hua1 (AUTHOR) luodh@sysucc.org.cn, Liu, Sai-Lan1 (AUTHOR) liusl@sysucc.org.cn, Guo, Ling1 (AUTHOR) guoling@sysucc.org.cn |
| Source: | British Journal of Cancer. Jun2026, Vol. 134 Issue 11, p1557-1567. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/s41416-026-03401-5 |
